BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19876070)

  • 1. Cell therapy strategies and improvements for muscular dystrophy.
    Quattrocelli M; Cassano M; Crippa S; Perini I; Sampaolesi M
    Cell Death Differ; 2010 Aug; 17(8):1222-9. PubMed ID: 19876070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration.
    Chan J; O'Donoghue K; Gavina M; Torrente Y; Kennea N; Mehmet H; Stewart H; Watt DJ; Morgan JE; Fisk NM
    Stem Cells; 2006 Aug; 24(8):1879-91. PubMed ID: 16675596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell therapies to treat muscular dystrophy: progress to date.
    Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
    BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current advances in cell therapy strategies for muscular dystrophies.
    Negroni E; Vallese D; Vilquin JT; Butler-Browne G; Mouly V; Trollet C
    Expert Opin Biol Ther; 2011 Feb; 11(2):157-76. PubMed ID: 21219234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cells and their potential in cell-based cardiac therapies.
    Christoforou N; Gearhart JD
    Prog Cardiovasc Dis; 2007; 49(6):396-413. PubMed ID: 17498520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating muscular dystrophy with stem cells?
    Davies KE; Grounds MD
    Cell; 2006 Dec; 127(7):1304-6. PubMed ID: 17190595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced stem cell activation and its implication for cardiovascular and skeletal muscle regeneration.
    Wahl P; Brixius K; Bloch W
    Minim Invasive Ther Allied Technol; 2008; 17(2):91-9. PubMed ID: 18465444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic strategy for muscular dystrophies].
    Shin JH; Takeda S
    Brain Nerve; 2007 Apr; 59(4):415-24. PubMed ID: 17447528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural commitment of embryonic stem cells: molecules, pathways and potential for cell therapy.
    Suter DM; Krause KH
    J Pathol; 2008 Aug; 215(4):355-68. PubMed ID: 18566959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in cell-based therapy for structural heart disease.
    Mazhari R; Hare JM
    Prog Cardiovasc Dis; 2007; 49(6):387-95. PubMed ID: 17498519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for muscular dystrophy: current progress and future prospects.
    Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G
    Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney repair using stem cells: myth or reality as a therapeutic option?
    Iwatani H; Imai E
    J Nephrol; 2010; 23(2):143-6. PubMed ID: 20175054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of stem cells in kidney disease.
    Chhabra P; Brayman KL
    Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges.
    Kaushal S; Jacobs JP; Gossett JG; Steele A; Steele P; Davis CR; Pahl E; Vijayan K; Asante-Korang A; Boucek RJ; Backer CL; Wold LE
    Cardiol Young; 2009 Nov; 19 Suppl 2():74-84. PubMed ID: 19857353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular therapy of muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional improvement of patients with progressive muscular dystrophy by bone marrow and umbilical cord blood mesenchymal stem cell transplantations].
    Yang XF; Xu YF; Zhang YB; Wang HM; Lü NW; Wu YX; Lü X; Cui JP; Shan H; Yan Y; Zhou JX
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(36):2552-6. PubMed ID: 20137617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience.
    Karussis D; Kassis I
    Clin Neurol Neurosurg; 2008 Nov; 110(9):889-96. PubMed ID: 18375051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle-derived stem cells: characterization and potential for cell-mediated therapy.
    Deasy BM; Jankowski RJ; Huard J
    Blood Cells Mol Dis; 2001; 27(5):924-33. PubMed ID: 11783957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies.
    Mimeault M; Hauke R; Batra SK
    Clin Pharmacol Ther; 2007 Sep; 82(3):252-64. PubMed ID: 17671448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.